Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Philip Adelson

Neurological Surgery Phoenix, AZ Medical Doctor

NPI 1942271317 CMS profile 314845

1919 E Thomas Rd, Phoenix Children's Hospital, Neurosurgery Department, Phoenix, AZ 85016

Open in the dashboard

General payments

$86,913

132 records reported · program years 2019–2025

Research payments

$10,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$43,720 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Philip Adelson of Phoenix, AZ is reported in the CMS Open Payments database as having received $86,913 across 132 general payments and $10,000 in research payments paid to them. Separately, studies naming them as principal investigator received $43,720 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,620 29
2024 General $17,490 26
2023 General $2,642 7
2022 General $141 6
2021 General $12,990 9
2020 General $29,639 36
2019 General $6,391 19
2019 Research $10,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Philip Adelson
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Philip Adelson were reported at $17,620. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Philip Adelson Neurological Surgery median Middle half National median
2019 $6,391 $582 $138–$3,006 $163
2020 $29,639 $294 $76–$2,174 $114
2021 $12,990 $387 $105–$2,432 $132
2022 $141 $542 $139–$2,989 $149
2023 $2,642 $534 $145–$2,697 $160
2024 $17,490 $574 $155–$3,046 $164
2025 $17,620 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $32,779 42 payments
  2. Medtronic, Inc. $28,341 31 payments
  3. LivaNova USA, Inc. $17,809 32 payments
  4. Microtransponder, Inc. $3,220 2 payments
  5. AveXis $2,377 2 payments
  6. Natus Medical Incorporated $1,500 1 payment
  7. Medical Device Business Services, Inc. $379 1 payment
  8. NeuroPace, Inc. $177 4 payments
  9. Ipsen Biopharmaceuticals, Inc $104 5 payments
  10. Piramal Critical Care $39 2 payments
  11. Other $188 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,541 21 payments
  2. Consulting Fee $18,045 7 payments
  3. Travel and Lodging $10,583 37 payments
  4. Honoraria $4,050 2 payments
  5. Food and Beverage $3,695 65 payments
Products named General payments · program years 2019–2025
  1. VISUALASE MRI-guided laser ablation $26,509 30 payments
  2. VISUALASE MRI-guided laser ablation $14,804 13 payments
  3. VNS THERAPY SENTIVA MODEL 1000 GENERATOR $12,035 17 payments
  4. Stealth Autoguide Image Guided Surgery Products $6,475 4 payments
  5. Stealth Autoguide Image Guided Surgery Products $4,865 4 payments
  6. StealthStation $4,255 2 payments
  7. VNS Therapy Neurology $2,931 10 payments
  8. VNS Therapy Cardiology/Vascular Diseases $2,550 1 payment
  9. ZOLGENSMA $2,377 2 payments
  10. MAZOR X SYSTEM $1,463 9 payments
  11. Other $2,986 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Integra LifeSciences Corporation $10,000 1 payment

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$8,858

Medicare's payments for the services billed

Medicare patients

17

Average age 66

Services billed

29

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 71%
Cancer 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

133 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record